INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Dec 09, 2020 |
EVP Finance CFO
Trans History: 310
|
EVP Finance CFO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,950 | -- |
| Dec 09, 2020 |
EVP General Counsel and Secret
Trans History: 123
|
EVP General Counsel and Secret | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,930 | -- |
| Dec 09, 2020 |
EVP General Counsel and Secret
Trans History: 123
|
EVP General Counsel and Secret | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,950 | -- |
| Dec 09, 2020 |
SVP Commercial
Trans History: 22
|
SVP Commercial | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,075 | -- |
| Dec 09, 2020 |
SVP Commercial
Trans History: 22
|
SVP Commercial | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- |
| Dec 09, 2020 |
SVP Commercial
Trans History: 22
|
SVP Commercial | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- |
| Dec 09, 2020 |
EVP Research
Trans History: 99
|
EVP Research | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,285 | -- |
| Dec 09, 2020 |
EVP Research
Trans History: 99
|
EVP Research | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,929 | -- |
| Dec 09, 2020 |
EVP Research
Trans History: 99
|
EVP Research | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- |
| Dec 09, 2020 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,688 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.